Condition: Alpha 1-Antitrypsin Deficiency · Emphysema · Sponsor: Sanofi
Phase 2 open label extension study to evaluate SAR447537 (INBRX-101) in adults with AATD emphysema
This description comes directly from the study's public registry record.
No contact information is available for this study as per the public registry record.
Always discuss trial participation with your own doctor first.
| UAB Lung Health Center- Site Number : 105 | Birmingham, Alabama, United States | — |
| St Joseph's Hospital and Medical Center- Site Number : 126 | Phoenix, Arizona, United States | — |
| David Geffen School of Medicine at UCLA- Site Number : 124 | Los Angeles, California, United States | — |
| University of California Davis Medical Center- Site Number : 110 | Sacramento, California, United States | — |
| National Jewish Medical and Research Center- Site Number : 123 | Denver, Colorado, United States | — |
| Nuvance Health Medical Practices, Pulmonary & Sleep Specialists- Site Number : 119 | Danbury, Connecticut, United States | — |
| University of Florida - Gainesville - 1600 SW Archer Rd- Site Number : 101 | Gainesville, Florida, United States | — |
| Indiana University- Site Number : 127 | Indianapolis, Indiana, United States | — |
| Brigham and Women's Hospital -75 Francis Street- Site Number : 131 | Boston, Massachusetts, United States | — |
| University of Minnesota-420 Delaware Str SE- Site Number : 125 | Minneapolis, Minnesota, United States | — |
| Hannibal Regional Healthcare System-HRMG-Hannibal- Site Number : 111 | Hannibal, Missouri, United States | — |
| Columbia University Irving Medical Center- Site Number : 104 | New York, New York, United States | — |
+ 28 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.